LATEST TRIALS

  • Lymphoma
    A Phase I/II Study of 177Lu-HH1 (Betalutin®) Radioimmunotherapy for Treatment of Relapsed Non-Hodgkin Lymphoma
  • MPNST
    A phase II study of pembrolizumab in patients with malignant peripheral nerve sheath tumor (MPNST), not eligible for curative surgery
  • Gastric Cancer
    A randomized phase II trial of imatinib alternating with regorafenib compared to imatinib alone for the first line treatment of advanced gastrointestinal stromal tumor (GIST)

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen